暫無數據
代碼股票名稱
最新價漲跌額漲跌幅成交量成交額今開昨收最高最低總市值流通市值總股本流通股本5日漲跌幅10日漲跌幅20日漲跌幅60日漲跌幅120日漲跌幅250日漲跌幅年初至今漲跌幅股息率TTM換手率市盈率TTM市盈率(靜)振幅所屬行業
美股市場個股詳情
CPHI 惠普森醫藥
- 0.3023
- -0.0237-7.27%
收盤價 04/26 16:00 (美東)
- 0.3192
- +0.0169+5.59%
盤後 18:53 (美東)
447.91萬總市值-332市盈率TTM
0.3249最高價0.3023最低價23.31萬股成交量0.3085今開0.3260昨收7.22萬成交額4.16%換手率虧損市盈率(靜)1481.69萬總股本2.695052周最高0.60市淨率169.38萬流通值0.271052周最低--股息TTM560.30萬流通股2044.2703歷史最高--股息率TTM6.93%振幅0.2710歷史最低0.3090平均價1股每手
全部分時
- 5日
- 日K
- 周K
- 月K
- 季K
- 年K
資金分布
單位: --
資金流向
實時日周月
暫無數據
新聞
週一盤前交易時段，12只醫療保健股走勢
在週一的盤前交易中，GainersGalera Therapeutics（納斯達克股票代碼：GRTX）股價上漲了62.8％，至0.23美元。他們已發行股票的市值爲1,230萬美元。根據新聞，t
週二盤後交易時段，12只醫療保健股走勢
在週二的盤後交易中，GainersLexaria Bioscience（納斯達克股票代碼：LEXX）股價上漲10.0％，至2.64美元。他們已發行股票的市值爲3,220萬美元。中國醫藥控股 (AMEX: C
中國醫藥控股宣佈反向股票拆分
惠普森醫藥將於2024年3月6日除權除息，5股合爲1股
2月24日消息，$惠普森醫藥(CPHI.US)$將於2024年3月6日除權除息，5股合爲1股。截至2月23日收市，$惠普森醫藥(CPHI.US)$報0.088美元，跌2.65%，當日成交額15.3万美元，總市值483.72万美元。什麼是合股？ 合股是拆股的相反過程，當股票價格較低時，爲了提升公司形象，上市公司會將已發行的股票按比例進行合併，即由多股合併爲1股。合股後，股價按照相應比例提高，股東權益
週五盤後交易時段，12只醫療保健類股走勢
在週五的盤後交易中，GainersOcean Biomedical（納斯達克股票代碼：OCEA）股價上漲37.6％，至2.16美元。該公司的市值爲7,360萬美元。NeuBase Therapeutics（納斯達克股票代碼：NBSE）股價上漲
快訊 | 中國醫藥控股宣佈以1比5的比例進行反向股票拆分
評論
$惠普森醫藥(CPHI.US$ Buy the dip...Upwards coming soon
$惠普森醫藥(CPHI.US$ Buy the dip...Upwards coming soon
$China Pharma (CPHI.US)$ Launch date is coming Up. Maxrale
China Pharma Holdings (NYSE:CPHI) stock soared 115% in morning trading Wednesday after the Chinese-American company said it is preparing to apply to launch its therapeutic device for dry eye disease in China.
China Pharma said in a statement that the product has finished third-party testing, with the company now preparing to apply to China's National Medical Products Administration for market clearance.
China Pharma Holdings (NYSE:CPHI) stock soared 115% in morning trading Wednesday after the Chinese-American company said it is preparing to apply to launch its therapeutic device for dry eye disease in China.
China Pharma said in a statement that the product has finished third-party testing, with the company now preparing to apply to China's National Medical Products Administration for market clearance.
1
Launch date is coming Up. Maxrale
China Pharma Holdings (NYSE:CPHI) stock soared 115% in morning trading Wednesday after the Chinese-American company said it is preparing to apply to launch its therapeutic device for dry eye disease in China.
China Pharma said in a statement that the product has finished third-party testing, with the company now preparing to apply to China's National Medical Products Administration for market clearance.
China Pharma Holdings (NYSE:CPHI) stock soared 115% in morning trading Wednesday after the Chinese-American company said it is preparing to apply to launch its therapeutic device for dry eye disease in China.
China Pharma said in a statement that the product has finished third-party testing, with the company now preparing to apply to China's National Medical Products Administration for market clearance.
$惠普森醫藥(CPHI.US$ Ready to move. tiny float
閱讀更多
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
漲跌幅